The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Adam Gray (D-CA), and Neal Dunn (R-FL) introduced the Protecting Patient Access to Cancer and Complex Therapies Act. This ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

Down here in Louisiana, we’ve got enough financial worries, especially after four years of Biden-induced inflation. Yet, ...

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since ...

As we age, prescription medications often become an essential part of managing our health. Whether it's for controlling blood pressure, treating diabetes or easing arthritis ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

Donald Trump and the GOP's so-called "Big Beautiful Bill" guts Medicaid to give tax breaks to the rich, but the legislation ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...